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Fungal natural products comprise a wide range of compounds. Some are medically
attractive as drugs and drug leads, some are used as food additives, while others are
harmful mycotoxins. In recent years the genome sequence of several fungi has become
available providing genetic information of a large number of putative biosynthetic pathways.
However, compound discovery is difﬁcult as the genes required for the production of the
compounds often are silent or barely expressed under laboratory conditions. Furthermore,
the lack of available tools for genetic manipulation of most fungal species hinders pathway
discovery. Heterologous expression of the biosynthetic pathway in model systems or cell
factories facilitates product discovery, elucidation, and production.This review summarizes
the recent strategies for heterologous expression of fungal biosynthetic pathways in
Aspergilli.
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INTRODUCTION
Filamentous fungi produce a plethora of secondary metabolites,
SMs, like polyketides (PK), terpenes, and non-ribosomal pep-
tides (NRP). Several fungal SMs dramatically impact human
life either because they are harmful mycotoxins, like carcino-
genic aﬂatoxin (Eaton and Gallagher, 1994) and fumonisin (Voss
and Riley, 2013), or because they are used to efﬁciently combat
human disease, e.g., penicillin and lovastatin (Campbell and Ved-
eras, 2010). Importantly, analyses of fully sequenced fungi show
that the number of SMs known to be produced by these fungi
is too low to account for the number of genes and gene clus-
ters that potentially may lead to production of SMs (Szewczyk
et al., 2008). This strongly suggests that the chemical diversity of
the metabolomes produced by ﬁlamentous fungi is much larger
than what is currently known, and it is therefore very likely
that new harmful mycotoxins and new blockbuster drugs await
discovery.
The rapid accumulation of fully sequenced genomes has accel-
erated the discovery of novel SMs dramatically. However, this
sequence resource cannot be directly translated into chemical
structures of new compounds despite that genes and gene clus-
ters are often readily identiﬁed by bioinformatics tools (Khaldi
et al., 2010; Andersen et al., 2013; Blin et al., 2013). For exam-
ple, the exact structures of products released by fungal type I
polyketide synthases are difﬁcult to predict due to the iterative
use of the different catalytic domains in these enzymes. Sim-
ilarly, subsequent decorations performed by tailoring enzymes
encoded by other genes in the cluster toward formation of the
mature end product(s) are complex and not easy to predict.
Another challenge is that many SMs are not readily produced
under laboratory conditions although several approaches have
been successfully employed to activate silent clusters (for reviews,
see Brakhage and Schroeckh, 2011; Chiang et al., 2011; Klejnstrup
et al., 2012; Wiemann and Keller, 2014; Yaegashi et al., 2014). To
link novel SMs to genes, and to map novel biosynthetic path-
ways, extensive genetic manipulations of the strains are typically
required. Since, most new gene clusters uncovered by sequenc-
ing projects will be situated in fungi with no available genetic
tools, this type of analysis may not be straight forward. More-
over, it may be difﬁcult to purify sufﬁcient amounts of a desired
compound from these fungi to allow for thorough characteri-
zation of its bioactivity. An alternative approach is to transfer
genes and gene clusters to hosts with strong genetic toolboxes
thereby facilitating product discovery, production, and charac-
terization. Here we review SM production in Aspergilli based
cell factories. Considerations and strategies concerning central
steps toward fungal SM production are presented for inspira-
tion: choice of host, how to produce the ﬁrst intermediate in
the pathway, and how to establish the remaining part of the
pathway.
HOST CHOICE FOR HETEROLOGOUS EXPRESSION OF FUNGAL
SECONDARY METABOLITES
Heterologous expression of SM genes has mainly been performed
in baker’s yeast Saccharomyces cerevisiae (Tsunematsu et al., 2013)
and in the ﬁlamentous fungi Aspergillus oryzae and A. nidulans.
Each of these model organisms offers speciﬁc advantages. For S.
cerevisiae a superior genetic toolbox for strain construction has
been developed and novel genes can easily be engineered into
a wealth of single- and multi-copy expression plasmids or into
chromosomes. For example, gene targeting and fusion of DNA
fragments by homologous recombination (HR) is highly efﬁcient
in S. cerevisiae. Moreover, S. cerevisiae contains an insigniﬁcant
endogenous secondary metabolism (Siddiqui et al., 2012). This
fact simpliﬁes the analysis of strains equipped with new path-
ways as they are not complicated by the presence of a multitude
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of other SMs; and the risk of undesirable side reactions due to
cross chemistry between the novel and endogenous pathways is
minimized. However, lack of secondary metabolism also means
that yeast is not naturally geared for SM production and may con-
tain limiting amounts of, or even lack, relevant building blocks
(Kealey et al., 1998; Mutka et al., 2006). Moreover, localization of
relevant enzymes for aﬂatoxin production into specialized vesicles
in A. parasiticus indicate that fungi may possess specialized com-
partments for SM production, which yeast may not contain (Roze
et al., 2011); and as introns are few in S. cerevisiae (Spingola et al.,
1999) and differ from those in ﬁlamentous fungi (Kupfer et al.,
2004), mRNA splicing could be problematic. For these reasons
ﬁlamentous fungi may often be more appropriate for heterol-
ogous SM production. A. oryzae is often used for this purpose
because it possesses a limited endogenous secondary metabolism
and A. nidulans because a strong genetic toolbox has been devel-
oped for this fungus (for review see, Meyer, 2008; Meyer et al.,
2011). Importantly, the recent development of efﬁcient tools for
gene targeting in ﬁlamentous fungi, including strains where ran-
dom integration is minimized due to mutation of genes required
for non-homologous end-joining (Ninomiya et al., 2004; Nayak
et al., 2006; Takahashi et al., 2006), has further stimulated the
use of these organisms as hosts for SM pathway reconstitution
experiments.
HETEROLOGOUS EXPRESSION OF POLYKETIDE SYNTHASES
The fact that the product(s) released by fungal type I PK synthases
(PKSs) cannot easily be predicted from their primary sequence
has sparked a major interest in expressing PKS genes in model
fungi with the aim of identifying these products. In yeast, two
2 μ based multi-copy plasmids harboring the 6-methylsalicylic
acid (6-MSA) synthase gene from Penicillium patulum and the
PKS activating PPTase gene from Bacillus subtilis were successfully
used to produce 6-MSA (Kealey et al., 1998). Similarly produc-
tion of green pigment has been achieved in a wA yA (white)
A. nidulans (Holm, 2013) via co-expression of the PKS gene wA
and laccase gene yA harbored on two AMA1 (Aleksenko and
Clutterbuck, 1997) based plasmid. However, if multiple plas-
mids are needed to form a complex end-product, these vectors
may have limited value since sufﬁcient markers may not be avail-
able, and since 2 μ and AMA1 plasmids segregate unevenly
during mitosis (Albertsen et al., 2011; Holm, 2013; Jensen et al.,
2014).
More stable expression has been achieved by integrating PKS
genes randomly into the genome of a model ﬁlamentous fungus
via the non-homologous end-joining pathway. Using this con-
cept, Fujii et al. (1996) successfully linked 6-MSA production to
the PKS gene atX from A. terreus by expressing atX host A. nidu-
lans. Considering that foreign SMs may be toxic in the new host,
it is advisable to employ an expression strategy that minimizes
this risk. For production of 6-MSA and enniatins in A. nidulans
and A. niger, this was achieved by fusing the PKS and NRPS genes
to the inducible promoters, amyB (Fujii et al., 1996) and Tet-on
(Richter et al., 2014), respectively. Over the years, a number of
other PKS genes have been linked to products using this strategy
in A. nidulans and A. oryzae including the PKS genes for pro-
duction of 1,3,6,8-tetrahydroxynaphthalene, alternapyrone, and
3-methylorcinaldehyde by (Fujii et al., 1999, 2005; Bailey et al.,
2007).
Random integration may trigger unpredictable pleiotropic
effects that alter the expression of neighboring genes, hence, com-
plicating subsequent analyses (Verdoes et al., 1995; Palmer and
Keller, 2010). Moreover, since multiple copies of the gene often
integrate simultaneously into the same site, strains may suffer
genetic instability and lose expression over time. Taking advan-
tage of the development of strains and techniques for efﬁcient
gene targeting, these problems can be eliminated by inserting
genes into a deﬁned locus. This facilitates not only subsequent
strain characterization, but also sets the stage for experiments
analyzing mutant varieties of the gene where equal expression
levels of the alleles are important to fairly judge the impact of
individual mutations. Using this approach, Hansen et al. (2011)
demonstrated that mpaC from P. brevicompactum encodes a PKS
producing 5-methylorsellinic acid. In this case, mpaC was intro-
duced into a deﬁned site, IS1, on chromosome I of A. nidulans,
which supports expression of non-toxic genes in a variety of tissues
without affecting ﬁtness. Moreover, to simplify the integration
of genes into IS1, a set of vectors pre-equipped with targeting
sequences, genetic markers, promoters and terminators and a
USER-cloning cassette (Nour-Eldin et al., 2006) allowing for seam-
less ligation free insertion of relevant genes into the vector was
developed. Using this technology, ausA, from A. nidulans, and
yanA, from A. niger, have been shown to encode PKSs produc-
ing 3-,5-dimethyl orsellinic acid and 6-MSA, respectively (Nielsen
et al., 2011; Holm et al., 2014). In a variation of this approach,
Chiang et al. (2013) used fusion Polymerase chain reaction (PCR)
to merge an alcA promoter and PKS genes followed by integration
into the wA locus of A. nidulans. Correctly targeted transfor-
mants could therefore easily be identiﬁed as white colonies. The
authors expressed nine non-reducing (NR) PKS genes from A.
terrreus in this manner and identiﬁed six products. Heterolo-
gous production of PKs is complicated by the fact that not all
synthases possess a domain providing a product release mech-
anism (Awakawa et al., 2009; Du and Lou, 2010) and by the
fact that some PKSs require a starter unit different from Ac-
CoA (Hoffmeister and Keller, 2007). In the study by Chiang et al.
(2013), two of the nine NR-PKSs analyzed did not contain such
a domain and for one, a product was achieved by co-expressing a
gene encoding a thioesterase activity. In addition, two NR-PKS
were predicted to employ unusual starter units. For one NR-
PKS, production of this starter unit was successfully delivered by
co-expressing a gene encoding a highly reducing PKS and the col-
laborative effort of the two enzymes resulted in production of
an intermediate for production of asperfuranone (Chiang et al.,
2013).
TRANSFER OF GENE CLUSTERS TO HETEROLOGOUS HOSTS
Reconstitution of most SM pathways depends on the expression
of multiple genes since the SM scaffold delivered by the syn-
thase is further decorated by tailoring enzymes. Moreover, genes
providing transcriptions factors, transporters and/or a resistance
mechanism may also be required. Construction of strains for
heterologous end-product production is therefore a major chal-
lenge as it requires not only transfer, but also activation, of
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large gene clusters. Two principles are generally employed for
constructing DNA fragments that allow transfer of gene clus-
ters into another fungal host. Firstly, DNA fragments harboring
entire, or a large part of, gene clusters have been identiﬁed
in cosmid/fosmid libraries and transferred into vectors with a
selectable fungal marker (Figure 1A). Secondly, PCR fragments
covering the gene cluster have been stitched together using a
variety of methods including USER Fusion, Gateway cloning
and yeast recombination to create suitable transformation vec-
tors (Figure 1B). When gene clusters have been transformed
into the host, activation has been achieved by three different
methods. Firstly, in cases where the native gene cluster har-
bors a TF gene, it has been possible to activate the genes in
the cluster by equipping the TF gene with a constitutive or
inducible promoter known to work in the host. Secondly, in
gene clusters without a TF gene, activation has been achieved
either by overexpressing the global regulator LaeA or by indi-
vidually swapping cluster gene promoters for constitutive or
inducible promoters. Like for integration of PKS genes, and for the
same reasons, integration strategies based on random or directed
integration have beenused (Figure 1C). Inmany cases these strate-
gies have been combined and successful examples are provided
below.
Cosmids harboring the entire penicillin biosynthetic pathway
from P. chrysogenum were introduced to Neurospora crassa and
A. niger, resulting in the production of penicillin (Smith et al.,
1990). Similary, cosmids harboring the citrinin biosynthetic path-
way from Monascus purpureus and the monacolin K gene cluster
from Monascus pilosus were individually integrated into random
positions in the genome of A. oryzae. In the case of citrinin, the
transformant directly produced citrinin, but in small amounts.
However, as the cluster contains a TF gene, additional copies of the
activator gene (ctnA) controlled by the A. nidulans trpC promoter
were subsequently introduced in the strain to boost production.
Impressively, this resulted in a 400 fold increase of citrinin pro-
duction (Sakai et al., 2008). The monacolin K gene cluster does
not contain a TF gene. In this case, the cluster was activated by
overexpressing the gene encoding the global activator LaeA (Sakai
et al., 2012). A limitation of this strategy may be difﬁculties in iso-
lating cosmids containing a fragment that harbors the entire gene
cluster, especially if clusters are large. For example, the reconstruc-
tion of the terrequinone A gene cluster in A. oryzae was based on
a fosmid containing an incomplete gene cluster. The remaining
part of the cluster was subsequently obtained by PCR, cloned into
a vector and transformed into the A. oryzae strain harboring the
partial terrequinone A gene cluster (Sakai et al., 2012).
Several PCR based strategies have been used for transferring
gene clusters from the natural producer to a model fungus. For
clusters harboring a TF gene, PCR fragments covering the entire
gene cluster have been ampliﬁed, fused, and inserted via a single
cloning step into vectors predestined for site speciﬁc integration
in the genome of the host by HR. Multiple PCR fragments can
be orderly assembled by different strategies. For example, PCR
fragments of the geodin and neosartoricin B clusters were phys-
ically linked by E. coli based USER fusion and by yeast based
HR, respectively (Nielsen et al., 2013; Yin et al., 2013). Impor-
tantly, in both cases the promoter controlling expression of the
TF gene was swapped for a strong constitutive promoter dur-
ing the cluster re-assembly process. Large inserts (>15 kb) may
not be propagated stably in a cloning vector and large clusters
need to be subdivided into smaller fragment cassettes, which
together represent the entire cluster. Multiple subsequent inte-
grations depend on marker recycling, which can be achieved
by using pyrG as a selectable/counterselectable marker. A faster
method employs a two marker system for cluster transfer (Nielsen
et al., 2013). During one transformation cycle, one of the mark-
ers is used to select for integration of the ﬁrst cluster cassette
and the other marker for the next cassette. By ensuring that
integration of one cassette eliminates the marker contained by
the preceding cassette, numerous cluster cassettes can be inte-
grated sequentially by alternating the use of the two markers.
Advantageously, when the gene clusters is inserted in a con-
trolled manner it can be subjected to further genetic dissection
to clarify the biochemical pathway toward end product. With
the geodin cluster this was exploited to demonstrate that gedL
encodes a halogenase using sulochrin as substrate (Nielsen et al.,
2013).
Polymerase chain reaction based reconstruction of clusters that
do not contain an activating TF gene requires more elaborate
genetic engineering as all cluster genes need to be equipped with
newpromoters and terminators. In one strategy, clusterORFswere
inserted either individually or in pairs into expression cassettes in
plasmids carrying different selection markers. Using this approach
several small gene clusters containing four to ﬁve genes have been,
fully or partially, reconstituted by randomly introducing the genes
into the genome of A. oryzae. Several SMs have been achieved by
this method including tennelin, pyripyropene, aphidicolin, ter-
retonin, and andrastin A (Heneghan et al., 2010; Itoh et al., 2010;
Fujii et al., 2011; Matsuda et al., 2012,2013). Constructionof larger
clusters in A. oryzae has been limited by the number of available
markers. To bypass this problem, Tagami et al. (2013, 2014) used
the high co-transformation frequency with A. oryzae to integrate
twovectors inone roundof transformationusing selection for only
one marker. This allowed for reconstituting clusters with six and
seven genes for production of paxilline and aﬂatrem, respectively
(Tagami et al., 2013, 2014). Addressing the same problem, Gate-
way cloning was used to construct expression vectors containing
up to four genes (Pahirulzaman et al., 2012; Lazarus et al., 2014).
Utilizing this approachWasil et al. (2013) expressed different com-
binations of the synthase and tailoring genes from the aspyridone
pathway from A. nidulans in A. oryzae. An alternative approach to
save markers is to generate synthetic polycistronic genes where all
genes in the construct are under the control of a single promoter
and where all ORFs are separated by a sequence encoding the viral
2A peptide that results in co-translational cleavage, hence, result-
ing in the formation of independent enzymes (Kim et al., 2011).
Using this concept Unkles et al. (2014) reconstituted the penicillin
gene cluster from P. chrysogenum as a single three ORF polystronic
gene by yeast mediated HR. Random genomic integration of this
construct resulted in penicillin production in A. nidulans.
A strategy for gene cluster activation based on pro-
moter/terminator swapping has also been implemented in gene
cluster transfer methods where genes are inserted into deﬁned
integration sites (Hansen et al., 2012; Mikkelsen et al., 2012;
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FIGURE 1 | Overview of principles employed for constructing DNA fragments (A,B) and for integration in host genomes (C).
Chiang et al., 2013). Speciﬁcally, expression plasmids containing
one to two cluster genes were constructed by USER cloning or by
fusion PCR and integrated into the expression sites in S. cerevisiae
and A. nidulans to allow for production of the pigment precursor
rubrofusarin in yeast (Rugbjerg et al., 2013) and for partial and
fully reconstitution of the pathways for mycophenolic acid and
asperfuranone production, respectively, in A. nidulans (Hansen
et al., 2012; Chiang et al., 2013).
PERSPECTIVES
The rapid development of molecular tools for cluster trans-
fer and re-engineering in heterologous hosts is now at a stage
where high-throughput experiments can be performed, and we
therefore predict that novel SMs, genes, pathways and enzymes
routinely will be discovered using this approach. For now most
efforts have been proof of principle cases analyzing genes and
gene clusters from genetically well-characterized organisms, but
the next wave of breakthroughs will likely concern SMs orig-
inating from genetically exotic fungi. In addition, the natural
reservoir of SMs will likely expand dramatically as synthetic
biology based approaches using bio-bricks of promoters, termi-
nators and SM genes are combined in intelligent or in random
ways in model fungi to deliver compounds that nature never
invented. Together, we envision that heterologous production
will serve as a major driver for SM discovery and development
delivering compounds that can be used in the food and pharma
industries. Accordingly, physiologically well-characterized fun-
gal cell factories should preferentially be employed as platforms
for novel SMs discovery and development. These fungi display
superior fermentation properties and extensive metabolic engi-
neering toolboxes, hence, shortening the way toward large scale
production.
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